Micron Technology Available For Sale Securities Debt Securities Current increased by 16.0% to $681.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $663.00M to $681.00M. Over 5 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows an upward trend with a 5.1% CAGR.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $590.00M | $870.00M | $900.00M | $1.01B | $1.07B | $1.07B | $1.01B | $1.02B | $1.05B | $1.02B | $973.00M | $990.00M | $785.00M | $1.07B | $895.00M | $663.00M | $648.00M | $665.00M | $587.00M | $681.00M |
| QoQ Change | — | +47.5% | +3.4% | +11.8% | +6.4% | -0.1% | -5.8% | +1.3% | +3.3% | -3.5% | -4.3% | +1.7% | -20.7% | +35.7% | -16.0% | -25.9% | -2.3% | +2.6% | -11.7% | +16.0% |
| YoY Change | — | — | — | — | +81.4% | +22.9% | +11.9% | +1.4% | -1.5% | -4.9% | -3.4% | -2.9% | -25.5% | +4.7% | -8.0% | -33.0% | -17.5% | -37.6% | -34.4% | +2.7% |